Cell Therapy Against Cerebral Stroke Comprehensive Reviews for Translational Researches and Clinical Trials

This book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke. Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell trans...

Full description

Bibliographic Details
Other Authors: Houkin, Kiyohiro (Editor), Abe, Koji (Editor), Kuroda, Satoshi (Editor)
Format: eBook
Language:English
Published: Tokyo Springer Japan 2017, 2017
Edition:1st ed. 2017
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02661nmm a2200337 u 4500
001 EB001345130
003 EBX01000000000000000899320
005 00000000000000.0
007 cr|||||||||||||||||||||
008 170203 ||| eng
020 |a 9784431560593 
100 1 |a Houkin, Kiyohiro  |e [editor] 
245 0 0 |a Cell Therapy Against Cerebral Stroke  |h Elektronische Ressource  |b Comprehensive Reviews for Translational Researches and Clinical Trials  |c edited by Kiyohiro Houkin, Koji Abe, Satoshi Kuroda 
250 |a 1st ed. 2017 
260 |a Tokyo  |b Springer Japan  |c 2017, 2017 
300 |a X, 156 p. 15 illus., 11 illus. in color  |b online resource 
505 0 |a Part I. Optimal Cell Sources -- 1. Bone Marrow-Derived Mononuclear Cells -- 2. Mesenchymal Stem Cells / Bone Marrow Stromal Cells -- 3. Neural Stem Cells / Neuronal Progenitor Cells -- 4. iPS Cells / iN -- Part II. Translational Research -- 5. Cell Culture -- 6. Cell Dose, Timing and Route -- 7. Scaffold -- 8. Cell Tracking -- 9. Functional Bio-Imaging -- Part III. Clinical Trials -- 10. Review of Previous Clinical Trials and Guideline of Cell Therapy -- 11. Bone Marrow-Derived Mononuclear Cells -- 12. Mesenchymal Stem Cells 
653 |a Neurosurgery 
653 |a Regenerative Medicine/Tissue Engineering 
653 |a Neurology  
653 |a Neurosurgery 
653 |a Neurology 
653 |a Tissue engineering 
653 |a Regenerative medicine 
700 1 |a Abe, Koji  |e [editor] 
700 1 |a Kuroda, Satoshi  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
856 4 0 |u https://doi.org/10.1007/978-4-431-56059-3?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 617.48 
520 |a This book presents comprehensive reviews for both translational research and clinical trials on cell therapy for stroke. Cerebral stroke is still a leading cause of death and disability. However, despite intensive research, few treatment options are available. The therapeutic potential of cell transplantation has been studied for various pathological conditions of the central nervous system (CNS) including traumatic brain injury, traumatic spinal cord injury, degenerative disease, demyelinating disease and ischemic stroke, as the injured neural tissue in the CNS has only a limited regenerative capacity. Recently, a growing body of evidence in this field suggests that cell transplantation holds great potential as a form of stroke therapy. The authors, who are experts in the field of neurosurgery, review and discuss optimal cell sources and various issues involved in translational research; further, they outline ongoing clinical trials in Japan